Therapeutic Areas – Neurology
Within one of the longstanding GreenLight Medicines Ltd. neurological disease research programmes, tests on a plant-derived psychoactive compound within a model of addiction have shown promising results. The work conducted with world renowned neuropharmacology researchers at UCD has indicated that biological pathways associated with opiate addiction can be reversed back to a normal state.
This programme co-funded by the Irish Research Council and charitable donations will now investigate if these biological changes are long lived and importantly if they translate into behavioural changes. A distinct UCD based research programme will investigate if plant-based compounds can alleviate neuro-inflammatory changes associated with Alzheimer’s disease.